Noemi
Rebollo Díaz
Publicacions en què col·labora amb Noemi Rebollo Díaz (7)
2022
-
Long-term effectiveness and pharmacokinetics of the infliximab biosimilar CT-P13 after switching from the originator during the treatment of inflammatory bowel disease
European Journal of Hospital Pharmacy, Vol. 29, Núm. 4, pp. 222-227
-
Population pharmacokinetics of a posaconazole tablet formulation in transplant adult allogeneic stem cell recipients
European Journal of Pharmaceutical Sciences, Vol. 168
2021
-
Comparison of ultra-performance liquid chromatography and ARK immunoassay for therapeutic drug monitoring of voriconazole
Annals of Clinical Biochemistry, Vol. 58, Núm. 6, pp. 657-660
-
Relación entre las concentraciones séricas de vedolizumab en fase de inducción y respuesta temprana y mantenida en el primer año de tratamiento en pacientes con colitis ulcerosa
Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria, Vol. 45, Núm. 7, pp. 38-44
2020
-
A 3-year prospective study of a multidisciplinary early proactive therapeutic drug monitoring programme of infliximab treatments in inflammatory bowel disease
British Journal of Clinical Pharmacology, Vol. 86, Núm. 6, pp. 1165-1175
-
Biomarkers of disease activity and other factors as predictors of adalimumab pharmacokinetics in inflammatory bowel disease
European Journal of Pharmaceutical Sciences, Vol. 150
2019
-
Therapeutic drug monitoring of tumour necrosis factor inhibitors in the management of chronic inflammatory diseases
Annals of Clinical Biochemistry, Vol. 56, Núm. 1, pp. 28-41